brimonidine


Also found in: Wikipedia.

brimonidine

 [brĭ-mo´nĭ-dēn]
an alpha-adrenergic receptor agonist used as the tartrate salt in treatment of open-angle glaucoma and ocular hypertension; administered topically to the conjunctiva.

brimonidine

A drug used in the form of eyedrops in the treatment of GLAUCOMA. The drug may be used when beta-blocker eyedrops are medically undesirable or when they are inadeqately effective in controlling the glaucoma. A brand name is Alphagan.
References in periodicals archive ?
She pointed to a 2017 study that examined a combination treatment of ivermectin 1% topical cream (Soolantra) and brimonidine 0.33% topical gel (Mirvaso) for patients with rosacea with moderate to severe persistent erythema and inflammatory lesions.
12 Which of the following statements regarding Brimonidine is false?
Among the new products, Bausch + Lomb's Lumify redness reliever eye drops are providing innovation and growth to the eye care category as the first and only O-T-C drops containing low-dose brimonidine tartrate.
Another study reported success when brimonidine 0.2% and timolol 0.5% were used together.
Bausch + Lomb announced the launch of LUMIFY, the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of eye redness.
Objective: To determine the efficacy of 0.2% brimonidine eye drops on control of intraocular pressure following Neodymium: Yttrium-Aluminum-Garnet (Nd: YAG) laser posterior capsulotomy.
IOP of the OD remained consistently above 50 mmHg with medications provided (i.e., travoprost, timolol, brinzolamide, brimonidine tartrate, and mannitol 20%).
M2 PHARMA-August 10, 2017-FDA Grants Ocugen Orphan Drug Designation for OCU300 (brimonidine tartrate) for Treatment of Ocular Graft Versus Host Disease
Healthcare company Perrigo Company plc (NYSE:PRGO)(TASE:PRGO) reported on Friday the receipt of tentative approval from the US Food and Drug Administration for the generic version of Mirvaso (brimonidine) topical gel 0.33% for the treatment of rosacea.
Timolol + brimonidine (30.76%) was the most frequently prescribed FDC followed by topical timolol + oral acetazolamide (26.92%) combination.
The IOP in the left eye was maintained in the teens with a regimen of brimonidine, dorzolamide, timolol, pilocarpine, and latanoprost.
Brimonidine. Brimonidine is an a2-adrenergic receptor agonist that is clinically used to lower IOP in glaucoma patients.